Bernie Sanders Just Broke With His Party Over This Trump Policy
Oh, Look Who Donated to Trump's White House Renovation Project
The Press Trips Over Themselves to Defend a Prosecutor, and Trump's Ballroom Project...
Sotomayor's Death Penalty Dissent Does More Harm Than Good
CNN’s Scott Jennings Drops Common Sense Truth Bomb on Geraldo Rivera Over ICE...
Keir Starmer Vows to Protect Britain's Muslim Migrants From the Legitimate Criticisms of...
Jay Jones Isn't Only Problem in His Family, Apparently
President Trump Deploys the Ford Carrier Strike Group to the Caribbean
The New York Knicks Issue Zohran Mamdani a Cease and Desist
This Top Democrat Just Endorsed a Socialist
Kentucky Waste Industry Mogul Promises to 'Take Out the Trash' in Washington DC
Pakistani National Sentenced to 40 Years for Smuggling Cruise Missiles, Warhead
Tennessee Attorney General Files Amicus Brief in US Supreme Court Opposing Birthright Citi...
Airline, Pilot Unions Demand That Democrats Reopen the Federal Government
Michigan Families Face SNAP Delays As Federal Shutdown Hits Day 23
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement